SCHEMBL13065352

SCHEMBL13065352

NC(=O)c1cccn([C@@H]2O[C@H](COC(=O)c3ccccc3)C(O)C2O)c1=O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
HTT P42858 1/20 0.47
P2RY6 Q15077 2/20 0.44
NT5E P21589 1/20 0.44
P2RY14 Q15391 1/20 0.44
P2RY2 P41231 1/20 0.41
P2RY4 P51582 1/20 0.41
ABCB1 P08183 1/20 0.41
ST6GAL1 P15907 1/20 0.41
PNP P00491 1/20 0.41
SLC5A2 P31639 1/20 0.41
GSK3A P49840 2/20 0.41
RPS6KA3 P51812 2/20 0.41
MAPK14 Q16539 2/20 0.41
LMNA P02545 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065638 0.81 SLC5A2 (0.56) ALDH1A1HTTSLC5A2LMNA
SCHEMBL13065336 0.80 ALDH1A1 (0.41) ALDH1A1HTTP2RY2P2RY4MEN1
SCHEMBL441997 0.79 LMNA (0.66) ALDH1A1HTTP2RY6NT5EP2RY14
SCHEMBL13678671 0.79 LMNA (0.66) ALDH1A1HTTP2RY6NT5EP2RY14
Hydrochloric Acid SCHEMBL11852550 0.78 LMNA (0.65) ALDH1A1HTTP2RY6NT5EP2RY14
SCHEMBL2984401 0.78 SLC28A1 (0.63) P2RY6P2RY14P2RY2P2RY4
SCHEMBL2984399 0.78 SLC28A1 (0.63) P2RY6P2RY14P2RY2P2RY4
SCHEMBL13065492 0.77 MEN1 (0.56) ALDH1A1HTTP2RY2MEN1USP2
SCHEMBL6273371 0.75 ALDH1A1 (0.53) ALDH1A1HTTLMNAPOLBKMT2A
SCHEMBL6273372 0.75 ALDH1A1 (0.53) ALDH1A1HTTLMNAPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100279974-A1 Nucleosides With Non-Natural Bases as Anti-Viral Agents IDENIX PHARMACEUTICALS, INC. 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279974-A1 Nucleosides With Non-Natural Bases as Anti-Viral Agents PNP, NSUN2, NME2 ALDH1A1 3538/4885HTT 2145/4885P2RY6 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.